These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1265 related items for PubMed ID: 18194136
1. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Tilg H, Moschen AR. Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136 [Abstract] [Full Text] [Related]
2. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757 [Abstract] [Full Text] [Related]
4. Adipokines: the missing link between insulin resistance and obesity. Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Diabetes Metab; 2008 Feb; 34(1):2-11. PubMed ID: 18093861 [Abstract] [Full Text] [Related]
5. Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come. Koerner A, Kratzsch J, Kiess W. Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):525-46. PubMed ID: 16311215 [Abstract] [Full Text] [Related]
6. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids. Chang YC, Chang TJ, Lee WJ, Chuang LM. Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775 [Abstract] [Full Text] [Related]
7. Adipokines as emerging mediators of immune response and inflammation. Lago F, Dieguez C, Gómez-Reino J, Gualillo O. Nat Clin Pract Rheumatol; 2007 Dec; 3(12):716-24. PubMed ID: 18037931 [Abstract] [Full Text] [Related]
8. Adipocytokines - novel link between inflammation and vascular function? Guzik TJ, Mangalat D, Korbut R. J Physiol Pharmacol; 2006 Dec; 57(4):505-28. PubMed ID: 17229978 [Abstract] [Full Text] [Related]
9. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. Moschen AR, Molnar C, Wolf AM, Weiss H, Graziadei I, Kaser S, Ebenbichler CF, Stadlmann S, Moser PL, Tilg H. J Hepatol; 2009 Oct; 51(4):765-77. PubMed ID: 19664840 [Abstract] [Full Text] [Related]
10. Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease. Schäffler A, Schölmerich J, Büchler C. Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):273-80. PubMed ID: 16265231 [Abstract] [Full Text] [Related]
11. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ. Calabro P, Yeh ET. Subcell Biochem; 2007 Jun; 42():63-91. PubMed ID: 17612046 [Abstract] [Full Text] [Related]
13. [Adipocytokines as mediators of metabolic role of adipose tissue]. Pandzić Jaksić V. Acta Med Croatica; 2010 Oct; 64(4):253-62. PubMed ID: 21688608 [Abstract] [Full Text] [Related]
14. Adipose tissue as an endocrine organ. Galic S, Oakhill JS, Steinberg GR. Mol Cell Endocrinol; 2010 Mar 25; 316(2):129-39. PubMed ID: 19723556 [Abstract] [Full Text] [Related]
15. Adiponectin and visfatin concentrations in children treated with valproic acid. Rauchenzauner M, Haberlandt E, Scholl-Bürgi S, Ernst B, Hoppichler F, Karall D, Ebenbichler CF, Rostasy K, Luef G. Epilepsia; 2008 Feb 25; 49(2):353-7. PubMed ID: 18070089 [Abstract] [Full Text] [Related]
16. Adipokines and etiopathology of metabolic disorders. Al-Dokhi LM. Saudi Med J; 2009 Sep 25; 30(9):1123-32. PubMed ID: 19750255 [Abstract] [Full Text] [Related]
17. Adipokines as uremic toxins. Teta D. J Ren Nutr; 2012 Jan 25; 22(1):81-5. PubMed ID: 22200420 [Abstract] [Full Text] [Related]
18. Review article: The role of adipose tissue in uraemia-related insulin resistance. Manolescu B, Stoian I, Atanasiu V, Busu C, Lupescu O. Nephrology (Carlton); 2008 Oct 25; 13(7):622-8. PubMed ID: 18826486 [Abstract] [Full Text] [Related]
20. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans. Laudes M, Oberhauser F, Schulte DM, Freude S, Bilkovski R, Mauer J, Rappl G, Abken H, Hahn M, Schulz O, Krone W. Horm Metab Res; 2010 Apr 25; 42(4):268-73. PubMed ID: 20091460 [Abstract] [Full Text] [Related] Page: [Next] [New Search]